<DOC>
	<DOCNO>NCT00454519</DOCNO>
	<brief_summary>OBJECTIVES : - Determine response survival patient peritoneal carcinomatosis treat cytoreductive surgery plus intraoperative peritoneal hyperthermic chemotherapy cisplatin mitomycin - Assess quality life patient treat regimen . OUTLINE : Patients randomize IPHC group control group . In former group , patient undergo cytoreductive surgery plus intraoperative hyperthermic peritoneal perfusion cisplatin mitomycin 60 minute . Patients control group underwent routine cytoreductive surgery . All patient group receive standard conventional chemotherapy surgery . Quality life assess study initiation , 1 , 3 , 6 month . Patients follow 4 week , every 3 month 1 year , every 6 month 3 year .</brief_summary>
	<brief_title>Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy ( IPHC ) Treat Peritoneal Carcinomatosis</brief_title>
	<detailed_description>DISEASE CHARACTERISTICS : - Histologically confirm peritoneal carcinomatosis follow histology : - Primary peritoneal mesothelioma - Adenocarcinoma gastrointestinal tract origin - Confined peritoneal cavity - Tumor mass could debulked less 2.5 cm diameter per tumor deposit - Must fail prior intraperitoneal platinum therapy - Treatment failure define radiographic evidence disease progression 2 consecutive CT scan within 3 month therapy PATIENT CHARACTERISTICS : Age : - 20 70 year old Performance status : - KPS &gt; 50 Life expectancy : - More 8 week Hematopoietic : - WBC least 3,500/mm^3 - Platelet count least 80,000/mm^3 Hepatic : - Bilirubin great 2 time upper limit normal ( ULN ) - AST ALT great 2 time ULN - Liver enzymes great 2 time ULN Renal : - Creatinine great 1.5 mg/dL Cardiovascular : - No significant irreversible cardiac ischemia - No significant change ECG record Pulmonary : - FEV_1 least 1.2 liter - Maximum voluntary ventilation least 50 % expect Other : - Not pregnant nursing - Negative pregnancy test - No concurrent medical problem would preclude surgery</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<criteria>Gastric cancer colorectal cancer peritoneal carcinomatosis Gastric cancer colorectal cancer malignant ascites Karnofsky Performance Scale ( KPS ) &gt; 50 Age less 20 year old , beyond 70 year old Any lung metastasis , liver metastasis , prominent retroperitoneal lymph node metastasis Bilirubin great 3 time upper limit normal ( ULN ) AST ALT great 5 time ULN Liver enzymes great 3 time ULN</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>peritoneal carcinomatosis</keyword>
	<keyword>cisplatin</keyword>
	<keyword>mitomycin</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>colorectal cancer</keyword>
</DOC>